Aclaris Long Term Debt from 2010 to 2025
| ACRS Stock | USD 1.82 0.01 0.55% |
Long Term Debt | First Reported 2015-12-31 | Previous Quarter 10.7 M | Current Value 10.7 M | Quarterly Volatility 11.4 M |
Check Aclaris Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aclaris Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 766.6 K, Interest Expense of 3.2 M or Selling General Administrative of 21.5 M, as well as many indicators such as Price To Sales Ratio of 9.73, Dividend Yield of 0.0 or PTB Ratio of 0.7. Aclaris financial statements analysis is a perfect complement when working with Aclaris Therapeutics Valuation or Volatility modules.
Aclaris | Long Term Debt |
Latest Aclaris Therapeutics' Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of Aclaris Therapeutics over the last few years. Long-term debt is a debt that Aclaris Therapeutics has held for over one year. Long-term debt appears on Aclaris Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Aclaris Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Aclaris Therapeutics' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aclaris Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Long Term Debt | 10 Years Trend |
|
Long Term Debt |
| Timeline |
Aclaris Long Term Debt Regression Statistics
| Arithmetic Mean | 6,542,069 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 125.33 | |
| Mean Deviation | 6,509,444 | |
| Median | 8,982,160 | |
| Standard Deviation | 8,198,918 | |
| Sample Variance | 67.2T | |
| Range | 29.9M | |
| R-Value | 0.59 | |
| Mean Square Error | 46.5T | |
| R-Squared | 0.35 | |
| Significance | 0.02 | |
| Slope | 1,024,269 | |
| Total Sum of Squares | 1008.3T |
Aclaris Long Term Debt History
Other Fundumenentals of Aclaris Therapeutics
About Aclaris Therapeutics Financial Statements
Aclaris Therapeutics shareholders use historical fundamental indicators, such as Long Term Debt, to determine how well the company is positioned to perform in the future. Although Aclaris Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Aclaris Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Aclaris Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Long Term Debt | 12.3 M | 9 M | |
| Short and Long Term Debt Total | 383.4 K | 364.2 K | |
| Short and Long Term Debt | 127.8 K | 113.6 K | |
| Long Term Debt Total | 9.6 M | 10.8 M | |
| Long Term Debt To Capitalization | 0.20 | 0.14 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aclaris Stock Analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.